- Home
- BMRA vs HOTH Comparison
BMRA vs HOTH Comparison
Compare BMRA & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- HOTH
- Stock Information
- Founded
- BMRA 1971
- HOTH 2017
- Country
- BMRA United States
- HOTH United States
- Employees
- BMRA N/A
- HOTH N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- HOTH Health Care
- Exchange
- BMRA Nasdaq
- HOTH Nasdaq
- Market Cap
- BMRA 8.1M
- HOTH 8.3M
- IPO Year
- BMRA N/A
- HOTH 2019
- Fundamental
- Price
- BMRA $3.09
- HOTH $1.14
- Analyst Decision
- BMRA
- HOTH Strong Buy
- Analyst Count
- BMRA 0
- HOTH 3
- Target Price
- BMRA N/A
- HOTH $4.00
- AVG Volume (30 Days)
- BMRA 26.1K
- HOTH 3.0M
- Earning Date
- BMRA 04-14-2025
- HOTH 05-12-2025
- Dividend Yield
- BMRA N/A
- HOTH N/A
- EPS Growth
- BMRA N/A
- HOTH N/A
- EPS
- BMRA N/A
- HOTH N/A
- Revenue
- BMRA $5,678,000.00
- HOTH N/A
- Revenue This Year
- BMRA N/A
- HOTH N/A
- Revenue Next Year
- BMRA N/A
- HOTH N/A
- P/E Ratio
- BMRA N/A
- HOTH N/A
- Revenue Growth
- BMRA 5.01
- HOTH N/A
- 52 Week Low
- BMRA $1.93
- HOTH $0.58
- 52 Week High
- BMRA $10.16
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- BMRA 45.39
- HOTH 51.11
- Support Level
- BMRA $3.03
- HOTH $1.15
- Resistance Level
- BMRA $3.44
- HOTH $1.34
- Average True Range (ATR)
- BMRA 0.19
- HOTH 0.13
- MACD
- BMRA 0.01
- HOTH -0.02
- Stochastic Oscillator
- BMRA 43.24
- HOTH 19.44
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.